The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas
The RNA-guided clustered regularly interspaced palindromic repeats (CRISPR)/associated nuclease 9 (Cas9)-based genome editing technology has increasingly become a recognized method for translational research. In oncology, the ease and versatility of CRISPR/Cas9 has made it possible to obtain many re...
Main Authors: | Silvia Pomella, Rossella Rota |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Chemistry |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fchem.2020.00178/full |
Similar Items
-
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas
by: Matteo Cassandri, et al.
Published: (2020-08-01) -
Etudes des translocations chromosomiques en utilisant les méthodes d'édition du génome : des mécanismes moléculaires à l’oncogenèse
by: Babin, Loélia
Published: (2019) -
CRISPR Gene Editing of Murine Blood Stem and Progenitor Cells Induces MLL-AF9 Chromosomal Translocation and MLL-AF9 Leukaemogenesis
by: Evgenia Sarrou, et al.
Published: (2020-06-01) -
Notch signaling in pediatric soft tissue sarcomas
by: Rota Rossella, et al.
Published: (2012-11-01) -
A One-Step PCR-Based Assay to Evaluate the Efficiency and Precision of Genomic DNA-Editing Tools
by: Diego Germini, et al.
Published: (2017-06-01)